Moreover, a significant increase in anti- Fn-Dps antibody levels was detected in II-IV-stage (n = 96) when compared to I-stage CRC patients (n = 27) (both P<0.05) (Fig 7E and 7F). This evidence concerns the gene PDSS1 and colorectal carcinoma.